{"id":"https://openalex.org/W2042166019","doi":"https://doi.org/10.2147/tcrm.s1277","title":"Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007","display_name":"Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007","publication_year":2008,"publication_date":"2008-11-01","ids":{"openalex":"https://openalex.org/W2042166019","doi":"https://doi.org/10.2147/tcrm.s1277","mag":"2042166019","pmid":"https://pubmed.ncbi.nlm.nih.gov/19436603","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2697541"},"language":"en","primary_location":{"id":"doi:10.2147/tcrm.s1277","doi":"https://doi.org/10.2147/tcrm.s1277","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s1277","pdf_url":"https://www.dovepress.com/getfile.php?fileID=3915","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=3915","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030763743","display_name":"Lawrence S. Chan","orcid":"https://orcid.org/0009-0007-0640-980X","observed_orcids":["https://orcid.org/0009-0007-0640-980X"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]},{"id":"https://openalex.org/I4210135737","display_name":"Jesse Brown VA Medical Center","ror":"https://ror.org/049qtwc86","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210115976","https://openalex.org/I4210135737"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lawrence Chan","raw_affiliation_strings":["Department of Dermatology","Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, IL, USA","Medicine Service, Jesse Brown VA Medical Center, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology","institution_ids":[]},{"raw_affiliation_string":"Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I39422238"]},{"raw_affiliation_string":"Medicine Service, Jesse Brown VA Medical Center, Chicago, IL, USA","institution_ids":["https://openalex.org/I4210135737"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5030763743"],"corresponding_institution_ids":["https://openalex.org/I39422238","https://openalex.org/I4210135737"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":2.3655,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.87641772,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"5","issue":"1","first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11627","display_name":"Autoimmune Neurological Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9850000143051147},{"id":"https://openalex.org/keywords/autoimmune-blistering-disease","display_name":"autoimmune blistering disease","score":0.9190000295639038},{"id":"https://openalex.org/keywords/pemphigus-vulgaris","display_name":"pemphigus vulgaris","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pemphigus-foliaceus","display_name":"pemphigus foliaceus","score":0.9229999780654907},{"id":"https://openalex.org/keywords/paraneoplastic-pemphigus","display_name":"paraneoplastic pemphigus","score":0.9419999718666077},{"id":"https://openalex.org/keywords/epidermolysis-bullosa-acquisita","display_name":"epidermolysis bullosa acquisita","score":0.9750000238418579},{"id":"https://openalex.org/keywords/bullous-pemphigoid","display_name":"bullous pemphigoid","score":0.9950000047683716},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.8289999961853027},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.8519999980926514},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.9409999847412109},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.7549999952316284},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.7580000162124634}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9643955230712891},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.6478843688964844},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5338714122772217},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.512829601764679},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3440297245979309},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26789456605911255},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.13128986954689026},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/tcrm.s1277","doi":"https://doi.org/10.2147/tcrm.s1277","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s1277","pdf_url":"https://www.dovepress.com/getfile.php?fileID=3915","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2697541","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2697541","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Clin Risk Manag","raw_type":"Text"},{"id":"pmid:19436603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19436603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and clinical risk management","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:45bab79498d54a00a9fd0d01199dc5d5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/45bab79498d54a00a9fd0d01199dc5d5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutics and Clinical Risk Management, Vol 2009, Iss default, Pp 1-7 (2008)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/2627","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/effectiveness-and-side-effects-of-anti-cd20-therapy-for-autoantibody-m-peer-reviewed-article-TCRM","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/tcrm.s1277","doi":"https://doi.org/10.2147/tcrm.s1277","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s1277","pdf_url":"https://www.dovepress.com/getfile.php?fileID=3915","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2042166019.pdf","grobid_xml":"https://content.openalex.org/works/W2042166019.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W75619107","https://openalex.org/W92480372","https://openalex.org/W161677733","https://openalex.org/W883574872","https://openalex.org/W1497094314","https://openalex.org/W1579956540","https://openalex.org/W1722716127","https://openalex.org/W1774747311","https://openalex.org/W1862250341","https://openalex.org/W1980534680","https://openalex.org/W1985015727","https://openalex.org/W1988284734","https://openalex.org/W1999770818","https://openalex.org/W2000703193","https://openalex.org/W2002245044","https://openalex.org/W2014580374","https://openalex.org/W2029435743","https://openalex.org/W2034106417","https://openalex.org/W2036202025","https://openalex.org/W2037354541","https://openalex.org/W2039811370","https://openalex.org/W2043228997","https://openalex.org/W2047535890","https://openalex.org/W2051134648","https://openalex.org/W2057284793","https://openalex.org/W2059747952","https://openalex.org/W2061023878","https://openalex.org/W2061811357","https://openalex.org/W2067946410","https://openalex.org/W2072026763","https://openalex.org/W2074088798","https://openalex.org/W2088574571","https://openalex.org/W2091245624","https://openalex.org/W2103298864","https://openalex.org/W2110805805","https://openalex.org/W2119849564","https://openalex.org/W2127763108","https://openalex.org/W2135597948","https://openalex.org/W2147898473","https://openalex.org/W2154985299","https://openalex.org/W2162283821","https://openalex.org/W2168495534","https://openalex.org/W2168646211","https://openalex.org/W2315326266","https://openalex.org/W2317276018","https://openalex.org/W2417094601","https://openalex.org/W2419350377","https://openalex.org/W4253184949"],"related_works":["https://openalex.org/W7099373904","https://openalex.org/W3174821388","https://openalex.org/W2092254784","https://openalex.org/W2083263886","https://openalex.org/W1973454119","https://openalex.org/W2029435743","https://openalex.org/W4387921077","https://openalex.org/W181375786","https://openalex.org/W2781645293","https://openalex.org/W1544852200"],"abstract_inverted_index":{"In":[0],"order":[1],"to":[2,33,88,134],"examine":[3],"the":[4,10,36,84,118,157],"efficacy":[5],"and":[6,67,73,137,151],"side":[7,165],"effects":[8],"of":[9,25,42,94,100,107,122],"monoclonal":[11,85],"antibody":[12,86],"anti-CD20":[13],"(rituximab)":[14],"on":[15,170],"autoimmune":[16],"blistering":[17],"skin":[18],"diseases,":[19],"we":[20],"performed":[21],"a":[22,130,139,177],"comprehensive":[23],"survey":[24],"71":[26],"consecutive":[27],"patients":[28,46,95,101,108,126,146],"from":[29],"initial":[30],"use":[31],"up":[32],"2007,":[34],"using":[35],"PubMed":[37],"database.":[38],"A":[39],"heterogeneous":[40],"group":[41],"patients,":[43],"including":[44],"51":[45],"with":[47,51,55,59,63,69,117,120,127,138,172],"pemphigus":[48,52,56],"vulgaris,":[49],"one":[50,68],"vegetans,":[53],"nine":[54],"foliaceus,":[57],"five":[58],"paraneoplastic":[60,128],"pemphigus,":[61,129],"four":[62,121],"epidermolysis":[64],"bullosa":[65],"acquisita,":[66],"both":[70],"bullous":[71],"pemphigoid":[72],"graft":[74],"vs":[75],"host":[76],"disease":[77,131],"was":[78],"included":[79],"in":[80,91,115,125],"this":[81],"survey.":[82],"Overall":[83],"seems":[87],"be":[89],"effective":[90],"that":[92],"69%":[93],"showed":[96,102,109],"complete":[97,160],"response,":[98,104],"25%":[99],"partial":[103],"whereas":[105],"6%":[106],"progressive":[110],"disease.":[111],"Six":[112],"deaths":[113,124],"occurred":[114],"association":[116],"treatment,":[119],"these":[123],"characteristically":[132],"resistant":[133],"conventional":[135],"medication":[136],"high":[140],"mortality":[141],"rate.":[142],"Of":[143],"note,":[144],"11":[145],"who":[147],"received":[148],"combined":[149],"rituximab":[150,171],"intravenous":[152],"immune":[153],"globulin":[154],"treatments":[155],"had":[156],"best":[158],"outcome:":[159],"response":[161],"without":[162],"any":[163],"serious":[164],"effects.":[166],"Therefore":[167],"further":[168],"investigation":[169],"controlled":[173],"clinical":[174],"trial":[175],"is":[176],"worthy":[178],"pursuit.":[179]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}